HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ana Muntañola Selected Research

Residual Neoplasm

10/2022Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial.
6/2006Clinical significance of minimal residual disease, as assessed by different techniques, after stem cell transplantation for chronic lymphocytic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ana Muntañola Research Topics

Disease

6B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
12/2013 - 06/2006
3Lymphoma (Lymphomas)
04/2020 - 04/2005
2Residual Neoplasm
10/2022 - 06/2006
2Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
10/2017 - 12/2014
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
04/2017 - 01/2006
2Neoplasms (Cancer)
04/2017 - 11/2013
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
10/2022
1Cerebellar Diseases (Cerebellar Syndrome)
10/2022
1Hematologic Neoplasms (Hematological Malignancy)
10/2022
1T-Cell Lymphoma (Lymphoma, T Cell)
04/2020
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
04/2017
1Paralysis (Palsy)
01/2017
1Multiple Myeloma
01/2017
1Ataxia (Dyssynergia)
11/2013
1Essential Thrombocythemia
08/2010
1Hemorrhage
08/2010
1Thrombosis (Thrombus)
08/2010
1Venous Thrombosis (Deep-Vein Thrombosis)
08/2010
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
04/2005
1Infarction (Infarctions)
03/2003
1Abdominal Pain (Pain, Abdominal)
03/2003

Drug/Important Bio-Agent (IBA)

5Rituximab (Mabthera)FDA Link
10/2022 - 09/2009
5fludarabineIBA
04/2017 - 01/2008
5Mitoxantrone (Novantrone)FDA LinkGeneric
04/2017 - 01/2008
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2017 - 03/2003
2Bendamustine HydrochlorideFDA Link
10/2017 - 12/2014
2Biological ProductsIBA
01/2006 - 04/2005
1ibrutinibIBA
10/2022
1Cytarabine (Cytosar-U)FDA LinkGeneric
10/2022
1Anaplastic Lymphoma KinaseIBA
04/2020
1Bortezomib (Velcade)FDA Link
01/2017
1ChromatinIBA
11/2013
1Apoptosis Regulatory ProteinsIBA
11/2013
1Cyclin D1IBA
11/2013
1Toll-Like Receptor 2IBA
11/2013
1GlucocorticoidsIBA
11/2012
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
08/2010
1insulin receptor-related receptor (IRR)IBA
08/2010
1Monoclonal AntibodiesIBA
09/2009
1ElementsIBA
01/2008
1DNA (Deoxyribonucleic Acid)IBA
01/2008
1Etoposide (VP 16)FDA LinkGeneric
01/2008
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2008
1Histones (Histone)IBA
01/2008
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
04/2005
1Prednisone (Sone)FDA LinkGeneric
03/2003

Therapy/Procedure

5Therapeutics
04/2017 - 01/2008
2Drug Therapy (Chemotherapy)
10/2022 - 09/2009
1Aftercare (After-Treatment)
01/2008
1Stem Cell Transplantation
06/2006